Subscribe to this collection to receive daily e-mail notification of new additions

Issue Date	Title	Author(s)
2014-05	Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences	Mahesh, R.
2014-09	Antidepressant-like effect of a novel 5-HT3 receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests	Mahesh, R.
2013-06	2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carboxylic acids: Novel 5-HT3 receptor antagonists with anxiolytic-like activity in rodent behavioral models	Mahesh, R.
2016-09	Neuropharmacological and neurochemical evaluation of N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT3 receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats	Mahesh, R.
2015	Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery	Mahesh, R.
2010-01	Anti-Depressant-Like Activity of Mucuna Pruriens; A Traditional Indian Herb in Rodent Models of Depression	Mahesh, R.; Jhadav, Hemant R.
2011-01	Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists	Mahesh, R.
2012-09	Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT3 receptor antagonist: An investigation in behaviour-based rodent models of depression	Mahesh, R.
2013-07	Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats	Mahesh, R.
2013-12	Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5-HT3 Receptor Antagonists	Mahesh, R.
2013	Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests	Mahesh, R.
2014-11	Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety	Mahesh, R.
2014-06	Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of Depression	Mahesh, R.
2014-10	QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations	Mahesh, R.
2017-12	Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model	Mahesh, R.
2010-05	Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats	Mahesh, R.
2016-01	A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2- carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system	Mahesh, R.
2012-12	Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)	Mahesh, R.
2014	Anti-anxiety effect of a novel 5-HT3 receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice	Mahesh, R.
2013-11	QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice	Mahesh, R.